Chen JS - Search Results

1

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.

Chen JS, Hsu C, Chiang NJ, Tsai CS, Tsou HH, Huang SF, Bai LY, Chang IC, Shiah HS, Ho CL, Yen CJ, Lee KD, Chiu CF, Rau KM, Yu MS, Yang Y, Hsieh RK, Chang JY, Shan YS, Chao Y, Chen LT; Taiwan Cooperative Oncology Group. Chen JS, et al. Among authors: chen lt. Ann Oncol. 2015 May;26(5):943-949. doi: 10.1093/annonc/mdv035. Epub 2015 Jan 28. Ann Oncol. 2015. PMID: 25632066 Free article. Clinical Trial.

2

Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I-II trial.

Yang TS, Wang CH, Hsieh RK, Chen JS, Fung MC. Yang TS, et al. Among authors: chen js. Ann Oncol. 2002 Nov;13(11):1771-8. doi: 10.1093/annonc/mdf303. Ann Oncol. 2002. PMID: 12419750 Free article. Clinical Trial.

3

Specific inhibition of iNOS decreases the intestinal mucosal peroxynitrite level and improves the barrier function after thermal injury.

Chen LW, Hsu CM, Wang JS, Chen JS, Chen SC. Chen LW, et al. Among authors: chen sc, chen js. Burns. 1998 Dec;24(8):699-705. doi: 10.1016/s0305-4179(98)00114-4. Burns. 1998. PMID: 9915669

4

Changes in gut mucosal nitric oxide synthase (NOS) activity after thermal injury and its relation with barrier failure.

Chen LW, Hsu CM, Cha MC, Chen JS, Chen SC. Chen LW, et al. Among authors: chen sc, chen js. Shock. 1999 Feb;11(2):104-10. doi: 10.1097/00024382-199902000-00006. Shock. 1999. PMID: 10030796

5

Inhibition of inducible nitric oxide synthase (iNOS) prevents lung neutrophil deposition and damage in burned rats.

Chen LW, Hsu CM, Wang JS, Chen HL, Chen JS. Chen LW, et al. Among authors: chen hl, chen js. Shock. 2001 Feb;15(2):151-6. doi: 10.1097/00024382-200115020-00012. Shock. 2001. PMID: 11220644

6

Effects of bombesin on gut mucosal immunity in rats after thermal injury.

Chen LW, Hsu CM, Huang JK, Chen JS, Chen SC. Chen LW, et al. Among authors: chen sc, chen js. J Formos Med Assoc. 2000 Jun;99(6):491-8. J Formos Med Assoc. 2000. PMID: 10925556

7

Dermatophyte pseudomycetoma: a case report.

Chen AW, Kuo JW, Chen JS, Sun CC, Huang SF. Chen AW, et al. Among authors: chen js. Br J Dermatol. 1993 Dec;129(6):729-32. doi: 10.1111/j.1365-2133.1993.tb03342.x. Br J Dermatol. 1993. PMID: 8286261

8

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma.

Yang TS, Lin YC, Chen JS, Wang HM, Wang CH. Yang TS, et al. Among authors: chen js. Cancer. 2000 Aug 15;89(4):750-6. doi: 10.1002/1097-0142(20000815)89:4<750::aid-cncr5>3.0.co;2-r. Cancer. 2000. PMID: 10951336 Clinical Trial.

9

Presacral tumor: a review of forty-five cases.

Wang JY, Hsu CH, Changchien CR, Chen JS, Hsu KC, You YT, Tang R, Chiang JM. Wang JY, et al. Among authors: chen js. Am Surg. 1995 Apr;61(4):310-5. Am Surg. 1995. PMID: 7893093

10

Intensive chemotherapy plus recombinant human granulocyte-colony stimulating factor support for distant metastatic nasopharyngeal carcinoma. A preliminary report.

Wang CH, Wang HM, Chen JS, Chang WJ, Lai GM. Wang CH, et al. Among authors: chen js. Oncology. 1997 Jan-Feb;54(1):34-7. doi: 10.1159/000227658. Oncology. 1997. PMID: 8978590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,940 results

Search Page